XML 48 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Awards and Programs (Tables)
3 Months Ended
Mar. 31, 2013
Stock-Based Awards and Programs  
Schedule of compensation expense and tax benefits for stock-based awards and programs

We recognized the following amounts in compensation expense and tax benefits for all of our stock-based awards and programs for the applicable periods ended March 31 (in thousands):

 

 

 

Three Months Ended

 

Twelve Months Ended

 

 

 

2013

 

2012

 

2013

 

2012

 

Compensation expense

 

$

1,291

 

$

822

 

$

2,332

 

$

1,846

 

Tax benefit recognized

 

476

 

298

 

827

 

642

 

 

Schedule of assumptions used in valuation of performance-based restricted stock awards

 

 

 

 

Fair Value of Grants Outstanding at March 31,

 

 

 

2013

 

2012

 

Risk-free interest rate

 

0.12% to 0.32%

 

0.16% to 0.45%

 

Expected volatility of Empire stock

 

20.5%

 

21.5%

 

Expected volatility of peer group stock

 

12.1% to 30.8%

 

13.5% to 51.9%

 

Expected dividend yield on Empire stock

 

4.5%

 

4.9%

 

Expected forfeiture rates

 

3%

 

3%

 

Plan cycle

 

3 years

 

3 years

 

Fair value percentage

 

10.0% to 99.0%

 

41.0% to 104.0%

 

Weighted average fair value per share

 

$17.06

 

$13.63

 

 

Schedule of non-vested performance-based restricted stock awards (based on target number) and changes during the reporting period

 

 

 

 

2013

 

2012

 

 

 

Number
of shares

 

Weighted Average
 Grant Date Price

 

Number
of shares

 

Weighted Average
Grant Date Price

 

 

 

 

 

 

 

 

 

 

 

Outstanding at January 1,

 

33,900

 

$

20.25

 

37,400

 

$

19.28

 

Granted

 

26,300

 

$

21.36

 

10,000

 

$

20.97

 

Awarded

 

(4,460

)

$

18.36

 

(7,823

)

$

18.12

 

Not Awarded

 

(8,540

)

$

18.36

 

(5,677

)

$

18.12

 

 

 

 

 

 

 

 

 

 

 

Nonvested at March 31,

 

47,200

 

$

21.39

 

33,900

 

$

20.25

 

 

Schedule of fair value measurements for each grant year

 

 

 

 

Fair Value of Grants Outstanding at March 31

 

 

 

2013

 

2012

 

Total unrecognized compensation cost (in millions)

 

$0.3

 

Less than $0.1

 

Recognition period

 

1-3 years

 

1.75 years

 

Fair value

 

$19.63

 

$17.63

 

 

Schedule of shares of time-vested restricted stock granted to qualified individuals at the fair market value

 

 

 

 

March 31, 2013

 

March 31, 2012

 

 

 

 

 

Weighted

 

 

 

Weighted

 

 

 

Number of

 

Average Fair

 

Number of

 

Average Fair

 

 

 

shares

 

Market Value

 

shares

 

Market Value

 

Outstanding at January 1,

 

3,300

 

$

20.38

 

3,433

 

$

21.84

 

Granted

 

21,600

 

21.36

 

 

 

Vested

 

 

 

 

 

Distributed

 

 

 

 

 

(133

)

20.13

 

Forfeited

 

 

 

 

 

Vested but not distributed

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at end of period

 

24,900

 

$

22.40

 

3,300

 

$

20.38

 

 

Schedule of assumptions used in the valuations of stock options

 

 

 

 

Fair Value of Grants Outstanding at March 31,

 

 

 

2013

 

2012

 

Risk-free interest rate

 

0.11% to 0.28%

 

0.17% to 0.83%

 

Expected dividend yield

 

4.5%

 

4.9%

 

Expected volatility

 

24.0%

 

25.0%

 

Expected life in months

 

78

 

78

 

Market value

 

$22.40

 

$20.35

 

Weighted average fair value per option

 

$1.64

 

$1.56

 

 

Schedule of stock options activity

 

 

 

 

2013

 

2012

 

 

 

 

 

Weighted

 

 

 

Weighted

 

 

 

 

 

Average

 

 

 

Average

 

 

 

Options

 

Exercise Price

 

Options

 

Exercise Price

 

Outstanding at January 1,

 

163,300

 

$

23.15

 

190,300

 

$

21.56

 

Granted

 

 

 

 

 

Exercised

 

34,800

 

$

18.36

 

27,000

 

$

18.12

 

Outstanding at March 31,

 

128,500

 

$

23.15

 

163,300

 

$

22.13

 

Exercisable at March 31,

 

128,500

 

$

23.15

 

128,500

 

$

23.15

 

 

Schedule of aggregate intrinsic values of stock options

 

 

 

 

2013

 

2012

 

Aggregate intrinsic value (in millions)

 

Less than $0.1

 

Less than $0.1

 

Weighted-average remaining contractual life of outstanding options

 

2.8 years

 

3.9 years

 

Range of exercise prices

 

$21.79 to $23.81

 

$18.36 to $23.81

 

Total unrecognized compensation expense (in millions) related to non-vested options and related dividend equivalents granted under the plan

 

$0.0

 

Less than $0.1

 

Recognition period

 

 

 

Less than 1 year